J Gynecol Oncol.  2012 Jul;23(3):137-138. 10.3802/jgo.2012.23.3.137.

Screening of uterine cervical cancer in low-resource settings

• Lee JM

• KMID: 2245169
• DOI: http://doi.org/10.3802/jgo.2012.23.3.137

Abstract

No abstract available.

MeSH Terms

Mass Screening
Uterine Cervical Neoplasms

Reference

1. International Agency for Research on Cancer. GLOBOCAN 2008: cancer incidence and mortality worldwide in 2008 [Internet]. c2010. cited 2012 Jun 10. Lyon: International Agency for Research on Cancer;Available from: http://globocan.iarc.fr.

2. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001. 94:153–156.

3. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. J Natl Cancer Inst Monogr. 2003. (31):3–13.

4. World Health Organization. Cervical cancer screening in developing countries: report of a WHO consultation. 2003. Geneva: World Health Organization.

5. Singh E, Seth S, Rani V, Srivastava DK. Awareness of cervical cancer screening among nursing staff in a tertiary institution of rural India. J Gynecol Oncol. 2012. 23:141–146.

6. Nuranna L, Aziz MF, Cornain S, Purwoto G, Purbadi S, Budiningsih S, et al. Cervical cancer prevention program in Jakarta, Indonesia: See and Treat model in developing country. J Gynecol Oncol. 2012. 23:147–152.

7. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000. 132:810–819.

8. Miller AB, Sankaranarayanan R, Bosch FX, Sepulveda C. Can screening for cervical cancer be improved, especially in developing countries? Int J Cancer. 2003. 107:337–340.

9. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999. 354:20–25.

10. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer. 2001. 84:1616–1623.